A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

In the expanding field of peptide-based research, a combination of two bioactive molecules—BPC‑157 and TB‑500—has garnered ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Acute ischemic stroke caused by large-vessel occlusion demands rapid restoration of cerebral blood flow, and stent retrievers have evolved from ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

The United States acidity regulator market is projected to expand rapidly over the next decade, with industry value expected ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

FS, a trusted provider of ICT products and solutions, has unveiled its new 1.6T OSFP IHS (Closed Finned Top) optical ...

This useful study provides a systematic and solid comparison of sex-biased enteroendocrine peptide expression, including AstC and Tk, to show that these peptides contribute to female-biased fat ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...